While most of us can expect to live to around 80, some people defy expectations and live to be over 100.
There have been myriad scientific research efforts focused on stopping or slowing the effects of ageing.
A new review authored by three acclaimed geroscientists paints a promising picture of human clinical trials of prospective anti-aging drugs.
Since the time of the ancient Greeks, doctors and philosophers have argued whether ageing is a disease or a natural process.
Why do we age? It's a question that has had scientists scratching their heads for decades, but finally, we are starting to get some answers.
Research into the biology of ageing, and consequently extending the lifespan of humans, has become a serious endeavour.
Researchers have identified that removing harmful by-products of fat that naturally accumulate over time could do the trick.
Heading towards significant clinical use in the 2030s are senolytics and perhaps the first uses of partial reprogramming.
What allows some to be so vital in old age? Are they mere outliers, or can anyone, reach a ripe old age in good health?
The researchers managed to increase the lifespan of mice by an impressive 25% by deleting "senescent" cells.